From bedside to bench to bedside:
improving prognosis and treatment of prostate cancer.
Professor Lisa Butler’s research program examines the clinical journey of patients from surgery (bedside), to laboratory research (bench), through to novel clinical trial design (bedside).
Her goal is to improve treatment choices and outcomes for men with prostate cancer.
By developing more sensitive, non-invasive tests to monitor tumour behaviour, new therapies can be tailored to the patients who will benefit from them the most.